GlassScript

Teleflex LLC

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$26Mgeneral payments (2019-2025)
$0.00research payments (2019-2025)
25,691clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $358K
2020 $677K
2021 $3.7M
2022 $4.9M
2023 $5.2M
2024 $5.0M
2025 $6.5M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Urology $13M
Surgery $3.0M
Cardiovascular Disease $2.6M
Radiation Oncology $2.1M
Physician Assistant $893K
Interventional Cardiology $777K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Jeffrey Chambers Minneapolis, MN Cardiovascular Disease $2,118,362.86
Peter Walter Jamestown, NY Urology $1,332,164.56
Peter Orio Boston, MA Radiation Oncology $1,126,551.43
Gregg Eure Virginia Beach, VA Urology $1,019,883.59
Jonathan Thompson West Chester, OH Surgery $806,400.45
John Kaspar Raleigh, NC Urology $780,672.22
Steven Gange Slc, UT Urology $776,900.19
Thomas Mueller Linwood, NJ Urology $690,383.68
Janelle Bunce Jamestown, NY Physician Assistant $501,329.51
David Sussman Linwood, NJ Urology $424,722.26

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.